Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease (TARGET-IBD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03251118
Recruitment Status : Recruiting
First Posted : August 16, 2017
Last Update Posted : February 4, 2019
Sponsor:
Information provided by (Responsible Party):
Target PharmaSolutions, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2025
  Estimated Study Completion Date : July 2025